Literature DB >> 16362678

Headache and mood disorders.

Sergio de Filippis1, Emiliano Salvatori, Gabriella Coloprisco, Paolo Martelletti.   

Abstract

The aim of the study was to estimate the occurrence of mood, anxiety and disability disorders in 300 patients affected by chronic daily headache and MOH, who were observed for a 16-month period in our centre. We monitored the patients on an interview basis, concerning the anamnestic data collection related to the pre-morbid period, information given by relatives regarding the patient's behaviour during the day, attitudes towards others, maintenance of previous interests and enjoyments, and modifications of the biological rhythm. Several tests were conducted, underlining a significant correlation between headache and mood disorders, impairment of working activity, social and family life. The study shows that patients affected by chronic daily headache and MOH present high levels of anxiety, a depressive symptomatology associated with alexithymia. Moreover, it has been discovered that anxiety and depression facilitate the onset of headache, while patients suffering from pain persistence were more vulnerable to psychiatric problems. In consideration of these results, more exhaustive evaluations relating to the psychopathological aspects in patients affected by headache are necessary.

Entities:  

Mesh:

Year:  2005        PMID: 16362678      PMCID: PMC3452031          DOI: 10.1007/s10194-005-0199-5

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  2 in total

1.  Mental turmoil, suicide risk, illness perception, and temperament, and their impact on quality of life in chronic daily headache.

Authors:  Sergio De Filippis; Denise Erbuto; Federica Gentili; Marco Innamorati; David Lester; Roberto Tatarelli; Paolo Martelletti; Maurizio Pompili
Journal:  J Headache Pain       Date:  2008-10-25       Impact factor: 7.277

2.  Effect of biofeedback-assisted autogenic training on headache activity and mood states in Korean female migraine patients.

Authors:  Eun-Ho Kang; Joo-Eon Park; Chin-Sang Chung; Bum-Hee Yu
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.